Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
12.34
-0.24 (-1.91%)
At close: Dec 15, 2025, 4:00 PM EST
12.26
-0.08 (-0.65%)
After-hours: Dec 15, 2025, 7:54 PM EST
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$726,279
Profits / Employee
-$136,047
Market Cap
792.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 430 | -15 | -3.37% |
| Dec 31, 2023 | 445 | 30 | 7.23% |
| Dec 31, 2022 | 415 | 135 | 48.21% |
| Dec 31, 2021 | 280 | 101 | 56.42% |
| Dec 31, 2020 | 179 | 46 | 34.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARVN News
- 9 days ago - Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition - GlobeNewsWire
- 19 days ago - Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 21 days ago - Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire
- 5 weeks ago - Arvinas, Inc. (ARVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire